Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

OptimizeRx (OPRX) Net Income (2016 - 2025)

OptimizeRx's Net Income history spans 16 years, with the latest figure at $779000.0 for Q3 2025.

  • For Q3 2025, Net Income rose 108.54% year-over-year to $779000.0; the TTM value through Sep 2025 reached $4.8 million, up 115.2%, while the annual FY2024 figure was -$15.3 million, 12.82% up from the prior year.
  • Net Income for Q3 2025 was $779000.0 at OptimizeRx, down from $1.5 million in the prior quarter.
  • Across five years, Net Income topped out at $4.7 million in Q4 2024 and bottomed at -$11.7 million in Q4 2023.
  • The 5-year median for Net Income is -$2.9 million (2023), against an average of -$2.7 million.
  • The largest annual shift saw Net Income crashed 8790.01% in 2022 before it skyrocketed 140.19% in 2024.
  • A 5-year view of Net Income shows it stood at $623462.0 in 2021, then crashed by 152.26% to -$325836.0 in 2022, then tumbled by 3502.9% to -$11.7 million in 2023, then surged by 140.19% to $4.7 million in 2024, then crashed by 83.49% to $779000.0 in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Net Income are $779000.0 (Q3 2025), $1.5 million (Q2 2025), and -$2.2 million (Q1 2025).